stars 1 stars 2 stars 3

GlobalOne Sciences seeks novel, highly disruptive technologies, which we acquire for our select portfolio through outright purchase or in-licensing. We then fund the technical advancement of these technologies in order to bolster their commercial value, whether for eventual out-licensing, joint venturing, or premium divesture. Our assessment of disruptive technologies range from early inception to advanced prototyping to premarket approved technologies. We position advancement of research and development after securing funding opportunities in the US and/or around the world. Through our evaluation & commercialization pathway, we secure an exclusive licensing agreement for your technology of interest. Following this period we structure R&D partnerships and go-to-market strategies to help build toward a commercial product. When needed, we reach beyond our initial network to attract financing and sponsorships through strategic industrial or commercial partners. Always, we acquire opportunities ripe for market leadership. Imagine the idea Invent the innovation Impact the world

GlobalOne Sciences Questions

The GlobalOne Sciences annual revenue was $4 million in 2026.

GlobalOne Sciences is based in New York, New York.

The NAICS codes for GlobalOne Sciences are [541713, 541, 54171, 5417, 54].

The SIC codes for GlobalOne Sciences are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users